Pulmonary Hypertension Due to Lung Disease (Disorder)

Cardiovascular·MeSH: Hypertension, Pulmonary

Prevalence

47000.0 / 100K

Incidence

3000.0 / 100K/yr

1 drug in development·1 company·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)
DrugCompany
L606Liquidia Corp (LQDA)

Frequently asked questions

How many drugs are in development for Pulmonary Hypertension Due to Lung Disease (Disorder)?

BioSniper tracks 1 drug in development for Pulmonary Hypertension Due to Lung Disease (Disorder) across 1 company.

How many clinical trials target Pulmonary Hypertension Due to Lung Disease (Disorder)?

There are 1 clinical trial targeting Pulmonary Hypertension Due to Lung Disease (Disorder) tracked by BioSniper.

What is the prevalence of Pulmonary Hypertension Due to Lung Disease (Disorder)?

The estimated prevalence of Pulmonary Hypertension Due to Lung Disease (Disorder) is approximately 47000.0 per 100,000 population.

Deep-dive into Pulmonary Hypertension Due to Lung Disease (Disorder)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Pulmonary Hypertension Due to Lung Disease (Disorder) — Drugs in Development & Clinical Trials | BioSniper